| Result Update |
|
Maruti Suzuki India Reco: REDUCE CMP: Rs1,358 Target Price: Rs1,275 Royalty blues, Lower rating to REDUCE · Increase in royalty charge (at ~5.2% of sales vs ~3.6% earlier, results in sharp drop in APAT at Rs 5.1bn (24% below our est.). Royalty is now payable in Yen. · The sudden change in royalty charge overshadows otherwise strong operating performance. · Downgrade FY11E EPS by 16.6% to Rs 81.3 and FY12E EPS by 16.7% to Rs 88.9. Reduce TP to Rs 1,275 (down 23%) valuing at 7.5x EV/EBIDTA FY12 est (earlier 8.5x EV/EBIDTA). · Downgrade rating to REDUCE from ACCUMULATE. Key upsides arise from price hikes. Expect price hike in Sept/Oct. 1% change in domestic prices can impact our EPS by 9%.
Indian Oil Corporation Reco: BUY CMP: Rs372 Target Price: Rs392 Loss, But all is not lost · IOCL reported results which were below our estimates at EBIDTA and PAT Level, due to foreign exchange loss and non-issuance of oil bonds/Cash receivables during the quarter · Operating profit/ (loss) at (Rs.26.6bn), decline of 153.3% YoY, mainly due to forex loss of Rs.4.6bn and non issuance of oil bonds/cash receivables during the quarter · Average gross refining margin was at $3/bbl as compared to $7.4/bbl (decline of 59% YoY) below our expectation of $4.2/bbl · Valuations look attractive at 1.3x FY12E ABV, mainly due to recent change in reforms, Continue BUY rating with TP of Rs392
Hindustan Petroleum Corporation Reco: BUY CMP: Rs436 Target Price: Rs515 Times are getting better · HPCL reported results which were below our estimates at EBIDTA and PAT Level, primarily due to inventory loss and non-issuance of oil bonds/Cash receivables during the quarter · Operating profit/ (loss) at (Rs.15.3bn), (against our expectation of (Rs.5.7bn), decline of 215% YoY, mainly due to inventory loss of Rs13.9bn during the quarter · Average gross refining margin was at $3.72/bbl as compared to $5.7/bbl (decline of 34% YoY) in line with our expectation of $3.7/bbl. · Valuations look attractive at 1x FY12E ABV, mainly due to recent change in reforms, Continue BUY rating with TP of Rs515
Idea Cellular Reco: SELL CMP: Rs69 Target Price: Rs60 Traffic growth healthy, profits in-line, retain SELL · Q1FY11 EBIDTA at Rs8.9bn and PAT (after adjusting interest capitalization of Rs400mn) at Rs2bn, in line with estimates. · Comparable traffic growth of 13% QoQ and revenue growth of 5.4% healthy, and indicate reducing pricing pressure. · Increased capex guidance to Rs40-44bn and net-debt to Rs107bn push +ve FCF beyond FY12E. · Valuations expensive at 9.1x & 7.6x EV/EBIDTA for FY11E & FY12E respectively. Retain SELL with revised target Rs60.
Jaiprakash Associates Reco: ACCUMULATE CMP: Rs129 Target Price: Rs150 Margins nosedive - Downgrade earnings & rating · JPA's Q1FY11 net profit at Rs1.05 bn (-52% yoy) sharply below estimates (Rs2.57 bn). Revenues at Rs 31.7 bn , up 54% yoy, better than estimates of Rs29.15 bn · EBIT margins in the construction business at 7.3%, declined 992 bps on account of cost overruns at Srisailam & slower ramp up at Baglihar project · Cement EBIT margins at 19.9% nosedive (down 1194 bps) as increasing cost and 5.2% decline in cement realisation negates benefits of 60% growth in volumes · We downgrade our estimates for FY11E EPS by 16.5% (FY11 EPS - Rs 4.4 ) and FY12E EPS by 19.4% (FY12 EPS - Rs 5.3) – Lower target to Rs150 –rating to ACCUMULATE
Eicher Motor Reco: NOT RATED CMP: Rs966 Target Price: NR Strong results to support stock performance · Improving product mix and price hikes results in sales growth (66.7% YoY and -0.2% QoQ) higher than volume growth (19.1% YoY and -3.5% QoQ) · Higher staff cost and other expenses overshadow benefit of better product mix (flat RM to sales QoQ). EBIDTA margins decline 52 bps QoQ but improve 164 bps YoY to 8.2% · Net profit at Rs 522mn grows 178% YoY (38%QoQ) due to higher tax free treasury income of Rs 165mn on maturity of FMPs · Engine business with Volvo to commence in CY13. Upgrade CY11 EPS to by 6.1 % to Rs 89.1. Stock to outperform due to strong business outlook and surplus cash (~Rs 600 per share)
GlaxoSmithKline Pharma Reco: HOLD CMP: Rs2,054 Target Price: Rs2,020 Below expectations; Downgrade to Hold · Revenue growth of 10% is below our estimate of 16% mainly because of supply constraints in vaccine segment · Operating margins expanded by 144bps to 37.7% driven by favorable product mix · 46% decline in other income restricted APAT growth at 6% · Maintain our earning estimates of Rs70.3 and Rs80.8 for FY11E and FY12E respectively; Downgrade to Hold
Godrej Consumer Products Reco: ACCUMULATE CMP: Rs341 Target Price: Rs371 Below Expectation, Maintain 'ACCUMULATE' · Godrej Consumer Products (GCPL) consolidated performance was marginally below expectation, adjusted net profit of Rs894 mn versus expectation of Rs959 mn · Standalone performance below expectation, reported revenue decline of 5.4% yoy to Rs3.2 bn and adjusted net profit decline of 9.2% yoy to Rs548 mn · GCPL completed QIP of 15.4 mn shares at Rs345/Share and raised Rs5.3 bn. Resultant debt-equity at 1.4X · FY12E earnings fine-tuned - Rs18.7/Share to Rs19.0/Share. Maintain 'ACCUMULATE' with price target of Rs371/Share
NTPC Reco: ACCUMULATE CMP: Rs202 Target Price: Rs220 Profit Decline; Under-recovery at Kahalgaon & Farakka · Revenues grew by 8% yoy driven by flat volumes and 7.5% realization growth. Volumes flat due to Kahalgaon (2340MW) and Farakka (1600MW) operating at 61.5% and 73.7% PLF · EBITDA/PAT declined by 8%/16% yoy mainly due to under-recovery of capacity charges of Kahalgaon & Farakka led by lower than target (85%) utilizations (might be forced outages) · Forced outages most likely one time; more clarity in the analyst meet on 2nd august; to review earnings (Rs11.2/12.8 in FY11E/12E) post analyst meet · Valuations reasonable at 2.2xFY12E Book Value with core ROE of 28%, Maintain 'Accumulate' and price target of Rs220
United Phosphorus Reco: BUY CMP: Rs179 Target Price: Rs230 Results ahead of Estimates · UPL's Q1FY11 results were better than est. Despite 10% decline in revenues APAT grew by 17% · Results are adjusted for Rs 510 mn of M-T-M forex loss which is on account re-pricing of foreign liabilities · Management maintained its guidance for 8-10% topline growth and EBITDA margin expansion of 200 bps to 21% · We rollover our price target to FY12 est and reiterate BUY with price target of Rs 230 |
Safe Harbor:
The information contained and provided on this Website provides Investment advice for the education of investors. The posts are an information service only. Recommendations, opinions or suggestions are given with the understanding that readers acting on this information assume all risks involved. We do not assume any responsibility or liability resulting from the use of such information, judgment and opinions for Trading or Investment purposes.
You received this message because you are subscribed to the Google Groups "Investors Please Listen !" group.
To post to this group, send email to investorspleaselisten@googlegroups.com
To unsubscribe from this group, send email to
investorspleaselisten+unsubscribe@googlegroups.com For more options, visit this group at http://groups.google.com/group/investorspleaselisten?hl=en
1 comment:
It was a great blog i had ever read.Thanks for sharing the blog, seems to be interesting and informative too.Could you help me finfing more detail regarding bike insurance online
Post a Comment